IN8bio, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 8.56 million compared to USD 7.53 million a year ago. Basic loss per share from continuing operations was USD 0.2 compared to USD 0.3 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.01 USD | +1.00% | -28.93% | -27.90% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.90% | 44.12M | |
+15.61% | 122B | |
+19.26% | 113B | |
+3.61% | 22.66B | |
-18.20% | 21.34B | |
-41.55% | 16.92B | |
-14.87% | 16.68B | |
-16.03% | 16.61B | |
+1.79% | 13.62B | |
+24.29% | 11.04B |
- Stock Market
- Equities
- INAB Stock
- News IN8bio, Inc.
- IN8bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024